HealthPolitics

Britain’s Medical Cannabis Wall Is Tumbling Down

Published on June 28, 2018 · Last updated July 28, 2020
(RistoArnaudov/iStock)

Faced with the exigent needs of really sick kids, the UK government has said it is preparing to allow emergency use of medical cannabis within the next two weeks.

British patients who could benefit from cannabinoid therapies have little access to the types of formulations found in established medical cannabis markets like Canada, California, or Colorado. Meanwhile, Europe as a whole is flocking toward making medical cannabis therapies more available.

According to local reports, the issue has come into focus in the UK over several pediatric epilepsy cases like Alfie Dingley and Billy Caldwell, a 12 year-old Northern Ireland pediatric epilepsy patient.

British authorities seized Caldwell’s medication at London Heathrow Airport, sending him into a cascade of seizures requiring emergency attention. After Caldwell almost immediately suffered a seizure that hospitalized him, authorities gave him back his cannabidiol-rich medication—a high-CBD, low-THC mixture made by Canadian licensed producer Tilray and obtained during a trip to Canada. [Editor’s note: Tilray is owned by Privateer Holdings, a private equity firm that also owns Leafly.]

Starting in two weeks, doctors will be able to order cannabis medicines on an emergency basis. It’s not clear how many will be willing to do that. Patients must show “exceptional clinical need” and doctors—who aren’t generally trained on the endocannabinoid system—could reportedly be liable for patient outcomes.

This week, musician and activist Damian Marley joined with physicians to call on England to fully legalize medical cannabis.

Find Strains That Patients Say Help Treat Epilepsy

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.